advertisement

---

Xu F 16

Showing records 1 to 16 | Display all abstracts from Xu F

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Lin J
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Liao J; Lai Z
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Deng W; Liao J
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang G; Lin J
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Ke D
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Huang W
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Cui L; Zhong H
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Qin Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Huang K
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Chen Q; Hu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Jiang L; Chen Q
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Cheng Q
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Xu F
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Jiang L; Cui L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---

117189 BAFF deficiency aggravated optic nerve crush-induced retinal ganglion cells damage by regulating apoptosis and neuroinflammation via NF-κB-IκBα signaling
Tang F
International immunopharmacology 2024; 126: 111287

---

118313 Setanaxib mitigates oxidative damage following retinal ischemia-reperfusion via NOX1 and NOX4 inhibition in retinal ganglion cells
Zhong H; Li M; Wei Y; Xu F
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2024; 170: 116042

---